Risk of QTc Prolongation in a Cohort of Opioid-Dependent HIV-Infected Patients on Methadone Maintenance Therapy
Open Access
- 29 July 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 57 (8) , 1189-1194
Abstract
Background. Concern regarding the QTc interval in human immunodeficiency virus (HIV)–infected patients has been growing in recent years, and cases of prolonged QTc interval and torsades de pointes have been described in HIV-infected patients on methadone therapy. This study aimed to determine the prevalence and factors associated with long QTc interval in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy. Methods. A cross-sectional study was conducted in opioid-dependent HIV-infected patients on methadone maintenance therapy at a drug abuse outpatient center. Patients with any cardiac disease, drug-positive urine test, electrolyte abnormalities, and changes in their antiretroviral therapy (ART) or methadone doses in the last 2 months were excluded. Heart rate and QT interval in lead II were measured using the Bazett formula. Results. Ninety-one patients were included: 58 (63.7%) were men with a median age of 44.5 years and 68 of 91 (74.7%) were on ART. Median methadone dose was 70 mg/day (range 15–250 mg/day) and mean QTc interval was 438 ± 34 ms. Prolonged QTc interval (>450 ms) was documented in 33 of 91(36.3%) patients, and 3 of 91 (3.2%) had QTc >500 ms. On multiple linear regression analysis, methadone doses (P = .005), chronic hepatitis C–induced cirrhosis (P = .008), and being ART-naive (P = .036) were predictive of prolonged QTc. Conclusions. The prevalence of prolonged QTc interval in opioid-dependent HIV-infected patients on methadone maintenance therapy is high. Risk factors for prolongation of the QTc interval are chronic hepatitis C–induced cirrhosis, higher methadone doses, and being ART-naive. Thus, electrocardiographic monitoring is required to minimize cardiovascular morbidity and mortality in this specific HIV group.Keywords
This publication has 36 references indexed in Scilit:
- The Influence of Antiretroviral Therapy on the QTc Interval in an African CohortClinical Infectious Diseases, 2011
- Drug‐ and non‐drug‐associated QT interval prolongationBritish Journal of Clinical Pharmacology, 2010
- Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapyJournal of Infection, 2008
- Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patientsJournal of Infection, 2007
- Drug-induced long QT and torsade de pointes: recent advancesCurrent Opinion in Cardiology, 2007
- Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patientsJournal of Electrocardiology, 2006
- Blockade of HERG channels by HIV protease inhibitorsThe Lancet, 2005
- Long QTc and Torsades de Pointes in Human Immunodeficiency Virus DiseasePacing and Clinical Electrophysiology, 1997
- Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infectionClinical Autonomic Research, 1995
- Incidence of Cardiac Arrhythmias During Intravenous Pentamidine Therapy in HIV-Infected PatientsChest, 1994